Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
To cite: Elurbide J, Colyn L, Latasa MU, et al. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma. Gut 2025;74:116-127.Read the full arti…
Related Articles
Medical Mystery Solved — Led Astray | NEJM
This Double Take video from the New England Journal of Medicine describes the case of a man with persistent diffuse abdominal pain, fatigue, and anorexia…
Looking at Disease Course and Mortality in MASH Patients
A new study of patients with MASH shows a six-year mortality rate of 10% in patients with compensated cirrhosis.
Antiviral therapy for chronic hepatitis delta: new insights from clinical trials and real-life studies
Chronic hepatitis D (CHD) is the most severe form of viral hepatitis, carrying a greater risk of developing cirrhosis and its complications. For decades, pegylated…
Genomic and the tumor microenvironment heterogeneity in… : Hepatology
TMEs of IM and MO identified by whole-exome sequencing at single-cell resolution. Approach and Results: We performed parallel whole-exome sequencing and scRNA-seq on 23 samples…
Distinct immune microenvironment of venous tumor thrombus… : Hepatology
croenvironment in PVTT. Approach & Results: Time-of-flight mass cytometry (CyTOF) revealed that macrophages and monocytes were the dominant immune cell type in PVTT, with a…
Enhanced hepatitis B virus–specific immunity by combining… : Hepatology
mall surface viral antigen. Approach and Results: C57BL/6 mice were transduced with adeno-associated virus-HBV and were treated twice a week with HBV broadly neutralizing antibodies…
Stard1 promotes cholestatic liver injury and disease… : Hepatology
inly via the classic pathway and in a lower proportion through the mitochondrial acidic pathway. The latter requires STARD1-dependent cholesterol transport to the mitochondrial inner…
Ozempic & Weight Loss Drugs: How They Work in Your Brain | The Oprah Podcast
Subscribe: https://www.youtube.com/@oprahIn this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate pro…
Making America Healthy Again – Dr. Drew | Real Talk With Zuby Ep. 346
Dr. Drew is an American radio and TV personality, physician, and addiction medicine specialist. He joins Zuby to talk about his background and the intersecti…
Trends and cross-country inequality in the incidence of GI cancers among the working-age population from 1990 to 2021: a Global Burden of Disease 2021 analysis
Background GI cancers pose an increasing global health burden, with their impact on the working-age population (WAP) aged 15–64 years remaining largely unexplored despite the…